Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
Authors:
- Gerlinde VansantGVGerlinde Vansant
- Lenard S. VranckxLVLenard S. Vranckx
- Irena ZurnicIZIrena Zurnic
- Dominique Van LooverenDLDominique Van Looveren
- Paulien Van de VeldePVPaulien Van de Velde
- Christopher NoblesCNChristopher Nobles
- Rik GijsbersRGRik Gijsbers
- Frauke ChristFCFrauke Christ
- Zeger DebyserZDZeger Debyser
Open Access
- 2 April 2019
- journal article
- research article
- Published by Springer Nature in Retrovirology
- Vol. 16 (1) , 8
Abstract
Persistence of latent, replication-competent provirus is the main impediment towards the cure of HIV infection. One of the critical questions concerning HIV latency is the role of integration site selection in HIV expression. Inhibition of the interaction between HIV integrase and its chromatin tethering cofactor LEDGF/p75 is known to reduce integration and to retarget residual provirus to regions resistant to reactivation. LEDGINs, small molecule inhibitors of the interaction between HIV integrase and LEDGF/p75, provide an interesting tool to study the underlying mechanisms. During early infection, LEDGINs block the interaction with LEDGF/p75 and allosterically inhibit the catalytic activity of IN (i.e. the early effect). When present during virus production, LEDGINs interfere with proper maturation due to enhanced IN oligomerization in the progeny virions (i.e. the late effect). We studied the effect of LEDGINs present during virus production on the transcriptional state of the residual virus. Infection of cells with viruses produced in the presence of LEDGINs resulted in a residual reservoir that was refractory to activation. Integration of residual provirus was less favored near epigenetic markers associated with active transcription. However, integration near H3K36me3 and active genes, both targeted by LEDGF/p75, was not affected. Also in primary cells, LEDGIN treatment induced a reservoir resistant to activation due to a combined early and late effect. LEDGINs present a research tool to study the link between integration and transcription, an essential question in retrovirology. LEDGIN treatment during virus production altered integration of residual provirus in a LEDGF/p75-independent manner, resulting in a reservoir that is refractory to activation.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek
- Onderzoeksraad, KU Leuven (OT/13/098)
- HIV-ERA EURECA (ZL345530)
- KU Leuven Interdisciplinary Research program (IDO/12/008)
- Belgian IAP Belvir (ZKC4893-P7/45-P)
This publication has 99 references indexed in Scilit:
- Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stageRetrovirology, 2013
- LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virionsRetrovirology, 2013
- Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturationProceedings of the National Academy of Sciences, 2013
- Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomesNucleic Acids Research, 2013
- Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase MultimerizationAntimicrobial Agents and Chemotherapy, 2012
- New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of ActionJournal of Biological Chemistry, 2012
- Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase InhibitorsJournal of Biological Chemistry, 2012
- Allosteric Inhibitor Development Targeting HIV‐1 IntegraseChemMedChem, 2011
- LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integrationGenes & Development, 2007
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997